Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes
Open Access
- 1 November 2005
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 46 (11) , 2514-2524
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- An improved assay for platelet-activating factor using HPLC-tandem mass spectrometryJournal of Lipid Research, 2005
- Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometryJournal of Chromatography B, 2005
- Advanced glycation and endothelial functions: A link towards vascular complications in diabetesLife Sciences, 2004
- Rapid and selective identification of molecular species in phosphatidylcholine and sphingomyelin by conditional neutral loss scanning and MS 3Rapid Communications in Mass Spectrometry, 2004
- Collection of selected reaction monitoring and full scan data on a time scale suitable for target compound quantitative analysis by liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2003
- Synthetically prepared Amadori‐glycated phosphatidylethanolamine can trigger lipid peroxidation via free radical reactionsFEBS Letters, 2000
- Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic bloodFEBS Letters, 1996
- Chromatographic evidence for amadori product formation in rat liver aminophospholipidsLife Sciences, 1995
- Role of oxidized low density lipoprotein in atherogenesis.Journal of Clinical Investigation, 1991
- Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assayFree Radical Biology and Medicine, 1989